敲竹杠
发表于 2025-3-25 05:05:05
http://reply.papertrans.cn/27/2656/265513/265513_21.png
regale
发表于 2025-3-25 10:26:19
Dendritic Cells and HCMV Cross-Presentationted, immunosuppressive effects identical to those reported for MCMV can be suspected and we may then ask how a cytotoxic T lymphocyte (CTL) response is generated in these unfavourable conditions. In response to this question, cross-presentation of HCMV antigens by uninfected DCs to CD8. T cells coul
Gratulate
发表于 2025-3-25 13:10:14
http://reply.papertrans.cn/27/2656/265513/265513_23.png
寡头政治
发表于 2025-3-25 17:25:40
http://reply.papertrans.cn/27/2656/265513/265513_24.png
机制
发表于 2025-3-25 21:08:37
http://reply.papertrans.cn/27/2656/265513/265513_25.png
比赛用背带
发表于 2025-3-26 00:28:10
https://doi.org/10.1007/978-3-662-06508-2Antigen; Epstein-Barr Virus; HIV; Herpes Simplex Virus-1; Immunodeficiency Virus; cell; cells; dendritic ce
cravat
发表于 2025-3-26 04:51:16
http://reply.papertrans.cn/27/2656/265513/265513_27.png
使激动
发表于 2025-3-26 09:45:51
Michelle A. Sereno,Julianne DiCoccoopulations of DCs in culture, particularly immature DCs derived from blood monocytes and skin (Langerhans cells). However, there exist only a few instances in which HIV-1- or SIV-infected DCs have been identified in vivo in tissue sections. Second, different types of DCs reliably sequester and trans
Ischemia
发表于 2025-3-26 16:32:09
Nontraditional Options for Disseminationy, enabling its transport to lymphoid tissues, where DC-SIGN efficiently transmits low amounts of HIV-1 to T cells. The expression pattern of DC-SIGN in mucosal tissue, lymph nodes, placenta and blood suggests a function for DC-SIGN in both horizontal and vertical transmission of HIV-1. Moreover, th
反复无常
发表于 2025-3-26 17:09:22
Susan Flynn,Lucas Evans,Henry Sessangafree of EBV-associated malignancies because of effective T cell-mediated immune control of the virus. A better understanding of these highly efficient control mechanisms is important in the development of new treatment strategies for EBV-associated malignancies..A rational approach to EBV immunother